Our findings that MYO1E loss slows down tumor progression in a mouse model of breast cancer were further extended by performing meta-analysis of the relationship between MYO1E expression and breast cancer patient survival (Figure 5A, 5B), and supported by an earlier study on gene signature predicting patient outcome in breast cancer [17]. The gene discussed is MYO1E; the disease is breast carcinoma.